3,4-DIHYDROISOQUINOLIN-2(1H)-YL COMPOUNDS

The invention provides certain 3,4-dihydroisoquinolin-2(1H)-yl compounds, particularly compounds of formula I, and pharmaceutical compositions thereof. The invention further provides methods of using a compound of formula I to treat cognitive impairment associated with Parkinson's disease or sc...

Full description

Saved in:
Bibliographic Details
Main Authors CRAIG DANIEL WOLFANGEL, MATTHEW ROBERT REINHARD, CHRISTOPHER DAVID BEADLE, JOSEPH HERMAN KRUSHINSKI JR, JOHN MEHNERT SCHAUS, DAVID ANDREW COATES, JUNLIANG HAO
Format Patent
LanguageEnglish
Published 08.12.2020
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:The invention provides certain 3,4-dihydroisoquinolin-2(1H)-yl compounds, particularly compounds of formula I, and pharmaceutical compositions thereof. The invention further provides methods of using a compound of formula I to treat cognitive impairment associated with Parkinson's disease or schizophrenia.
Bibliography:Application Number: MY2015PI704341